- Research works
- 75 ▲ 286% vs 2018-21
- Citations
- 828 11.0 per fractional work
- Top-10% rate
- 20.9% all institutions 10.0%
- Open access
- 29% world 40%
- International
- 22% world 18%
Not ranked overall: Zymeworks (Canada) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Zymeworks (Canada) work in?
In 2022-now, 67% of research at Zymeworks (Canada) is in Health Sciences, 22% in Life Sciences. Its largest fields are Medicine (66%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (7%). It does 2.5× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 12 fields, with their numbers
- Health Sciences3567.0%
- Medicine3466.3%
- Health Professions00.6%
- Life Sciences1121.9%
- Physical Sciences610.7%
- Engineering24.5%
- Chemistry23.6%
- Materials Science11.3%
- Environmental Science01.0%
- Computer Science00.3%
- Social Sciences00.3%
- Social Sciences00.3%
What does Zymeworks (Canada) specialise in?
Where its research is concentrated relative to its size: Medicine takes 3.5× the share of its output that it takes of world research.
- MedicineField · 34.3 works3.5×
- Health SciencesDomain · 34.6 works2.9×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.6×. Every wedge is a field page.
All 12 fields, with their numbers
- Immunology and Microbiology6.60×3 works
- Medicine3.45×34 works
- Biochemistry, Genetics and Molecular Biology2.65×7 works
- Chemistry2.30×2 works
- Materials Science0.37×1 works
- Neuroscience0.30×0 works
- Engineering0.30×2 works
- Health Professions0.25×0 works
- Environmental Science0.19×0 works
- Agricultural and Biological Sciences0.15×0 works
- Computer Science0.04×0 works
- Social Sciences0.03×0 works
Who are the top researchers at Zymeworks (Canada)?
Ranked on the quality score, Nichole K. Escalante, Jamie R. Rich and Grant Wickman lead among researchers whose main affiliation is Zymeworks (Canada).
- 1
Nichole K. Escalante
Canada · #572,375 worldwide 1.2k citations · 26 works
- 2
Jamie R. Rich
Canada · #616,843 worldwide 1.8k citations · 101 works
- 3
Grant Wickman
Canada · #775,547 worldwide 2k citations · 61 works
- 4
Nicole J. Afacan
Canada · #947,603 worldwide 667 citations · 16 works
- 5
Vincent Fung
Canada · #1,029,419 worldwide 348 citations · 77 works
- 6
Maya C. Poffenberger
Canada · #1,083,400 worldwide 2.3k citations · 27 works
- 7
Jodi Wong
Canada · #1,195,871 worldwide 229 citations · 64 works
- 8
Andrea Hernández Rojas
Canada · #1,248,713 worldwide 238 citations · 64 works
- 9
Chayne L. Piscitelli
Canada · #1,332,020 worldwide 1.1k citations · 30 works
- 10
Raffaele Colombo
Canada · #1,425,907 worldwide 1.1k citations · 119 works
Which keywords describe research at Zymeworks (Canada)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Glycosylation, Breast Cancer, Monoclonal Antibodies, Fc Receptors, Therapeutic Antibodies, Receptor tyrosine kinases and HER2.
- Radioimmunotherapy
- Data Analysis
- Click Chemistry
- Cancer Therapy
- Epidemiology
- Targeted Therapy
- Soft Lithography
- Inflammation
- Chimeric Antigen Receptor
- Tumor Regression
- Immunotherapy
- HER2
- Therapeutic Antibodies
- Monoclonal Antibodies
- Glycosylation
- Chemotherapy
- Breast Cancer
- Fc Receptors
- Receptor tyrosine kinases
- Trastuzumab
- Cancer Immunotherapy
- CAR T Cells
- Cancer
- Nanolithography
- Metastatic Breast Cancer
- Drug Discovery
- Treatment
- PET Imaging
- Copper-Catalyzed Cycloaddition
- Gene Expression
- Radiopharmaceuticals
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 31 words, with their numbers
- Chemotherapy12▲ 32×5 topics
- Glycosylation11▲ 191×2 topics
- Breast Cancer10▲ 80×2 topics
- Monoclonal Antibodies10▲ 225×2 topics
- Fc Receptors10▲ 361×1 topic
- Therapeutic Antibodies10▲ 284×1 topic
- Receptor tyrosine kinases10▲ 482×2 topics
- HER210▲ 580×1 topic
- Trastuzumab10▲ 370×1 topic
- Immunotherapy6▲ 17×7 topics
- Cancer Immunotherapy6▲ 77×2 topics
- Tumor Regression6▲ 99×2 topics
- CAR T Cells5▲ 143×1 topic
- Chimeric Antigen Receptor5▲ 143×1 topic
- Cancer2▲ 2.7×7 topics
- Inflammation2▲ 1.61×6 topics
- Nanolithography2▲ 274×1 topic
- Soft Lithography2▲ 274×1 topic
- Metastatic Breast Cancer2▲ 52×2 topics
- Targeted Therapy2▲ 13×4 topics
- Drug Discovery1▲ 12×2 topics
- Epidemiology1▼ 0.68×4 topics
- Treatment1▲ 1.86×2 topics
- Cancer Therapy1▲ 3.9×3 topics
- PET Imaging1▲ 12×2 topics
- Click Chemistry1▲ 36×1 topic
- Copper-Catalyzed Cycloaddition1▲ 71×1 topic
- Data Analysis1▲ 7.4×2 topics
- Gene Expression1▲ 3.1×2 topics
- Radioimmunotherapy1▲ 70×1 topic
- Radiopharmaceuticals1▲ 70×1 topic
Which research topics does Zymeworks (Canada) publish most on?
By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, CAR-T cell therapy research and Nanofabrication and Lithography Techniques.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 10 works
- 2 HER2/EGFR in Cancer Research Oncology 10 works
- 3 CAR-T cell therapy research Oncology 5 works
- 4 Nanofabrication and Lithography Techniques Biomedical Engineering 2 works
- 5 Click Chemistry and Applications Organic Chemistry 1 works
- 6 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
- 7 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
- 8 Colorectal Cancer Treatments and Studies Oncology 1 works
- 9 IL-33, ST2, and ILC Pathways Immunology 1 works
- 10 Eosinophilic Esophagitis Surgery 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Zymeworks (Canada)'s research output changed?
Output in 2022-2025 was 286% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Zymeworks (Canada) as a percentage of every work published that year, 0.00014% in 2024.
Fractional works of Zymeworks (Canada) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Vancouver
- University of British Columbia
- TRIUMF
- Vancouver Coastal Health
- Columbia College
- Provincial Health Services Authority
- Quest University Canada
- Providence Health Care
- Children's & Women's Health Centre of British Columbia
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Zymeworks (Canada). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.